WordNet

English Journal

Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.

Derosa G1, Mugellini A2, Querci F3, Franzetti I4, Maria Pesce R2, D'Angelo A2, Maffioli P5.
Scientific reports.Sci Rep.2015 Aug 5;5:12603. doi: 10.1038/srep12603.
The aim of this study was to evaluate the effects of lercanidipine or barnidipine on echocardiographic parameters, in hypertensive, type 2 diabetics with left ventricular hypertrophy. One hundred and forty-four patients were randomized to lercanidipine, 20 mg/day, or barnidipine, 20 mg/day, in a
PMID 26243165

Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.

Na SH1, Lee HY1, Hong Baek S2, Jeon HK3, Kang JH4, Kim YN5, Park CG6, Ryu JK7, Rhee MY8, Kim MH9, Hong TJ10, Choi DJ11, Cho SW12, Cha DH13, Jeon ES14, Kim JJ15, Shin JH16, Park SH17, Lee SH18, John SH19, Shin ES20, Kim NH21, Lee SY22, Kwan J23, Jeong MH24, Kim SW25, Jeong JO26, Kim DW27, Lee NH28, Park WJ29, Ahn JC30, Won KH31, Uk Lee S32, Cho JH33, Kim SK34, Ahn T35, Hong S36, Yoo SY37, Kim SY38, Kim BS39, Juhn JH40, Kim SY40, Lee YJ40, Oh BH1.
Clinical therapeutics.Clin Ther.2015 Jul 8. pii: S0149-2918(15)00854-1. doi: 10.1016/j.clinthera.2015.05.512. [Epub ahead of print]
PURPOSE: The objective of this study was to evaluate the efficacy and safety of the lercanidipine/valsartan combination compared with lercanidipine monotherapy in patients with hypertension.METHODS: Part 1 of this study was the randomized, multicenter, double-blind, parallel group, Phase III, 8-week
PMID 26164786

Charfi O1, Lakhoua G2, Sahnoun R2, Daghfous R2, El Aidli S2, Kastalli S2, Zaïem A2.
Thérapie.Therapie.2015 Jul-Aug;70(4):381-3. doi: 10.2515/therapie/2015023. Epub 2015 May 8.
The spectrum of cutaneous eruptions associated with dihydropyridines is extensive, varying from exanthemas to severe adverse events. We report a case of bullous eruption, one month after starting nicardipine and lercanidipine. The same symptoms recurred few days after taking nitrendipine. © 2015 So
PMID 25957434